NHS England Agrees to Fund Everolimus for SEGA
We are delighted to announce that NHS England will now routinely fund Everolimus for inoperable TSC brain tumours (SEGA). This means that NHS England have reversed their previous decision made this summer when they had reached a decision that Everolimus was ‘unaffordable’. Jayne Spink, Chief